Health In Tech (HIT) Competitors $0.68 +0.02 (+2.82%) As of 04/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsTrendsBuy This Stock HIT vs. RDZN, ICCH, NEUE, ZBAO, AAME, FGF, HUIZ, OXBR, AIFU, and CNFRShould you be buying Health In Tech stock or one of its competitors? The main competitors of Health In Tech include Roadzen (RDZN), ICC (ICCH), NeueHealth (NEUE), Zhibao Technology (ZBAO), Atlantic American (AAME), Fundamental Global (FGF), Huize (HUIZ), Oxbridge Re (OXBR), AIX (AIFU), and Conifer (CNFR). These companies are all part of the "insurance" industry. Health In Tech vs. Roadzen ICC NeueHealth Zhibao Technology Atlantic American Fundamental Global Huize Oxbridge Re AIX Conifer Roadzen (NASDAQ:RDZN) and Health In Tech (NASDAQ:HIT) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, media sentiment, analyst recommendations, community ranking, earnings and risk. Which has stronger earnings & valuation, RDZN or HIT? Health In Tech has lower revenue, but higher earnings than Roadzen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRoadzen$42.89M1.85-$99.67M-$1.51-0.71Health In Tech$19.49M1.92N/AN/AN/A Do insiders and institutionals have more ownership in RDZN or HIT? 24.7% of Roadzen shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Do analysts recommend RDZN or HIT? Roadzen presently has a consensus price target of $5.00, indicating a potential upside of 367.29%. Given Roadzen's stronger consensus rating and higher possible upside, equities analysts clearly believe Roadzen is more favorable than Health In Tech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Roadzen 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Health In Tech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media refer more to RDZN or HIT? In the previous week, Health In Tech had 5 more articles in the media than Roadzen. MarketBeat recorded 6 mentions for Health In Tech and 1 mentions for Roadzen. Health In Tech's average media sentiment score of 0.28 beat Roadzen's score of -1.00 indicating that Health In Tech is being referred to more favorably in the news media. Company Overall Sentiment Roadzen Negative Health In Tech Neutral Is RDZN or HIT more profitable? Health In Tech has a net margin of 0.00% compared to Roadzen's net margin of -248.79%. Company Net Margins Return on Equity Return on Assets Roadzen-248.79% N/A -269.99% Health In Tech N/A N/A N/A Does the MarketBeat Community favor RDZN or HIT? Roadzen received 3 more outperform votes than Health In Tech when rated by MarketBeat users. CompanyUnderperformOutperformRoadzenOutperform Votes3100.00% Underperform VotesNo VotesHealth In TechN/AN/A SummaryRoadzen beats Health In Tech on 6 of the 11 factors compared between the two stocks. Get Health In Tech News Delivered to You Automatically Sign up to receive the latest news and ratings for HIT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HIT vs. The Competition Export to ExcelMetricHealth In TechInsurance Agents, Brokers & Service IndustryFinance SectorNASDAQ ExchangeMarket Cap$37.41M$37.41M$10.83B$7.35BDividend YieldN/AN/A5.98%4.30%P/E RatioN/AN/A21.6717.80Price / Sales1.921.9225.4397.74Price / CashN/AN/A17.6134.64Price / BookN/AN/A2.563.98Net IncomeN/AN/A$1.03B$247.73M7 Day Performance-2.14%-1.07%1.86%1.81%1 Month Performance1.05%0.52%-3.72%-6.98%1 Year PerformanceN/AN/A535.22%1.37% Health In Tech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HITHealth In TechN/A$0.69+2.8%N/AN/A$37.41M$19.49M0.0079Earnings ReportGap UpRDZNRoadzen1.3368 of 5 stars$1.31+14.9%$5.00+281.7%-80.5%$97.19M$42.89M-0.87324Short Interest ↑Positive NewsGap UpICCHICCN/A$23.49flatN/AN/A$73.74M$93.57M10.5890NEUENeueHealth1.1336 of 5 stars$6.12-6.3%$7.00+14.4%+9.6%$50.70M$936.66M-0.121,252ZBAOZhibao TechnologyN/A$1.02-12.8%N/A-74.1%$32.15M$183.67M0.00148Short Interest ↑Gap DownHigh Trading VolumeAAMEAtlantic American0.7429 of 5 stars$1.33-1.5%N/A-29.2%$27.14M$188.23M-3.80140Short Interest ↑Gap DownFGFFundamental Global2.0193 of 5 stars$16.50-5.1%N/A-54.8%$20.99M$28.64M12.609Short Interest ↓Gap UpHUIZHuize1.4709 of 5 stars$1.73-7.4%N/A-88.0%$17.22M$1.25B19.241,640Gap UpOXBROxbridge Re0.2268 of 5 stars$1.48+1.4%N/A+37.8%$11.02M$546,000.00-1.763Gap UpAIFUAIXN/A$0.15-5.0%N/AN/A$8.21M$2.36B0.205,780Positive NewsCNFRConifer1.4659 of 5 stars$0.62-9.2%N/A-42.7%$7.58M$66.30M0.26150Positive News Related Companies and Tools Related Companies Roadzen Competitors ICC Competitors NeueHealth Competitors Zhibao Technology Competitors Atlantic American Competitors Fundamental Global Competitors Huize Competitors Oxbridge Re Competitors AIX Competitors Conifer Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HIT) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health In Tech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Health In Tech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HIT Stock Free HIT Stock Alerts